Literature DB >> 4106696

Rifampicin: an immunosuppressant?

M Marija.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4106696     DOI： 10.1016/s0140-6736(71)92548-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  The effect of common antibiotics on lymphocyte transformation.

Authors:  W C Dam; F D Malkinson; H Gewurz
Journal:  Experientia       Date:  1975-03-15

2.  Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain.

Authors:  Xiaohui Wang; Peter M Grace; Michael N Pham; Kui Cheng; Keith A Strand; Christina Smith; Jing Li; Linda R Watkins; Hang Yin
Journal:  FASEB J       Date:  2013-04-08       Impact factor: 5.191

3.  Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses.

Authors:  Ke Ma; Xi Chen; Jia-Cheng Chen; Ying Wang; Xi-Meng Zhang; Fan Huang; Jun-Jiong Zheng; Xiong Chen; Wei Yu; Ke-Ling Cheng; Yan-Qing Feng; Huai-Yu Gu
Journal:  J Neurochem       Date:  2016-11-29       Impact factor: 5.372
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.